Sign in

CIK 0001812364 · Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Open-market sale See remarks sold 753 shares at $14.79 ($11,137)
  2. 4 Open-market sale President, R&D sold 1,490 shares at $14.79 ($22,037)
  3. ARS Other Annual Report to Security Holders
  4. DEFA14A Proxy Proxy Materials
  5. DEF 14A Proxy Proxy Statement
  6. 8-K Event Regulation FD disclosure · Other events
  7. PRE 14A Proxy Proxy Statement (Preliminary)
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. 4 Planned sale Chief Financial Officer sold 19,517 shares at an average $13.19 ($257,498)
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. 8-K Event Regulation FD disclosure · Other events
  13. 4 Planned sale Chief Financial Officer sold 17,717 shares at $10.06 ($178,233)
  14. 8-K Event Bylaws or fiscal year change
  15. 144 Insider Sale of Securities
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 4 of 28 · 556 filings